Fox Foundation gives $475,000 to Affiris to test its Parkinson's disease vaccine
This article was originally published in Scrip
Executive Summary
Vienna-based Affiris has received $475,000 funding from the Michael J Fox Foundation (MJFF) to complete preclinical development of its PD01 vaccine against Parkinson's disease. The company announced proof-of-concept for the vaccine last March (scripintelligence.com, 6 April 2010).